#4 Newsletter – JP Jenkins

Fourth Edition

This month we announced four new clients, saw trading volumes tick up and more brokers connect. Hoorah!

We are delighted to announce the following new admissions to JP Jenkins:

Molecular Energies (JPJ:MEN): Molecular Energies has four primary business divisions – an innovation arm focussing on the development of sustainable aviation fuel and other green energy solutions; ongoing receipts from the sale of its oil production operations in Argentina; a c18% holding in AIM-quoted ATOME plc, a green fertiliser project developer; and a 75% holding in Green House Capital Group, a carbon removal business focussed on biomass to biochar projects.

RedX Pharma (JPJ:REDX): Redx is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted medicines for the treatment of fibrotic disease, cancer and the emerging area of cancer-associated fibrosis. Peter Collum, Chief Financial Officer, Redx Pharma said,

“We are pleased to be able to offer our shareholders the ability to continue trading Redx shares on the JP Jenkins platform as a private company following the delisting from AIM. The JP Jenkins platform allows buying and selling of shares through a structured secondary market using brokers in the same manner as trading a listed security. This will allow us to focus on the execution of our corporate strategy, driving forward our pipeline of differentiated, novel drug candidates and ultimately delivering shareholder returns.”

E-therapeutics (JPJ:ETX): e-therapeutics combines computation and RNAi to discover and develop life-transforming medicines. The computational platform allows ETX to discover better medicines faster through generation of novel insights and increased automation across all stages of drug development. The Company is progressing a pipeline of highly differentiated RNAi therapies across a variety of therapeutic areas with high unmet need.

Scirocco Energy PLC (JPJ:SCIR): Scirocco Energy (“Scirocco”) is an investing company targeting attractive production and development opportunities within the European transition energy market. Scirocco Energy’s strategy is to acquire a diverse portfolio of direct and indirect interests in attractive production and development opportunities within the European transition energy market.

Issuer news – Check out the latest updates and news from our clients:

RedX Pharma: This month Redx Pharma’s CFO, Peter Collum, acquired 59,614 ordinary shares of the company at an average price of 20.87 pence per share, increasing his stake to 0.04% of the issued share capital.

Thrive Renewables: A solar panel business has secured £75m in funding from Bristol-based energy firm Thrive Renewables. Eden Sustainable, which operates around the UK including in Exeter and London, said the deal would accelerate the roll out of private wire solar power purchase agreement (PPA) projects for schools, businesses and organisations across the country.

Agronomics: Portfolio company Solar Foods Oy (“Solar Foods”) has raised an additional EUR8 million in funding via Finnish investment organiser Springvest Oyj.

Ienergizer: Air India augments customer care with 5 new centres globally. Partners with Concentrix and iEnergizer to provide 24/7 assistance for customers

Delistings

This month has been a month for delistings, not only in London but Europe too, where it was described by Euronews as ‘The Great Delisting’. A company delisting and moving onto JP Jenkins means its shareholders and future investors are still able to have shares bought and sold by UK regulated brokers and their price transparency and governance is maintained, albeit at a fraction of the cost.

We don’t actively seek delistings from the main markets, as we support companies on the path to IPO and those choosing to remain private too, but in the event a company does delist and comes over to JP Jenkins we like to  consider ourselves as a safety net for capital. We hope that by providing a facility for private liquidity in the UK, we might impede capital outflow to the likes of the US or act as a holding bay in case those companies that are delisting decide to relist in the future.

CISI events:

Our first event with The Chartered Institute for Securities & Investment ( CISI) as part of a three webinar series begins on 22 May. We will be  focusing on the evolving world of private securities. Earn CPD hours and learn about access to JP Jenkins as well as the private market environment both here and globally.  Sign up here.

As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com

Learning 101 with  JP Jenkins – Check out our latest videos here on:

Who is JP Jenkins?

Why do companies join?

How to trade?